Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Antacid/H2 use in arthritis patients taking NSAIDS may exacerbate GI risk -- study.

This article was originally published in The Tan Sheet

Executive Summary

ANTACID/H2 ANTAGONIST USE IN ARTHRITIS PATIENTS TAKING NSAIDS MAY INCREASE GI RISK, according to an article in the July 22 issue of the Archives of Internal Medicine. "Prophylactic treatment with antacids and H2 receptor antagonists [to combat GI side effects that result from frequent use of nonsteroidal anti-inflammatory drugs] is of questionable value and may increase the risk for subsequent serious GI complications" in rheumatoid arthritis sufferers, Gurkipal Singh, MD, Stanford University School of Medicine, et al. reported.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts